We're surrounded by manmade chemicals, from bits of dust in the air we breathe to the fabrics we wear. Not all are dangerous, though. Toxicologists like John Whysner, Ph.D. have the difficult task of determining which ones ...
May 27, 2021
0
1
A novel compound similar in structure to the psychedelic drug ibogaine, but lacking its toxic and hallucinogenic effects, has been found to rapidly reverse the effects of stress in mice.
May 25, 2021
3
172
Chronic inflammation of the pancreas is a debilitating disease with poorly understood causative factors. Now, researchers at Osaka University have identified the disturbed molecular pathways and revealed the underlying mechanisms ...
May 25, 2021
0
16
Alzheimer's disease is the main cause of dementia and current therapeutic strategies cannot prevent, slow down or cure the pathology. The disease is characterized by memory loss, caused by the degeneration and death of neuronal ...
May 25, 2021
0
10
Scientists at the University of York have made significant progress in the development of a nasal spray treatment for patients with Parkinson's disease.
May 24, 2021
0
17
Researchers at the University of Montreal Hospital Research Centre (CRCHUM) and Yale University have succeeded in reducing the size of the HIV reservoir in humanized mice by using a "molecular can opener" and a combination ...
May 20, 2021
0
4861
Despite the effectiveness of COVID-19 vaccines, treatments are still needed to combat this disease, which has killed millions of people and still kills thousands each day across the world. Scientists at the UNC School of ...
May 20, 2021
0
2
UCI scholars Zachary W. Wagoner, a graduate student researcher in cellular & molecular biosciences, and Weian Zhao, professor of pharmaceutical sciences, have identified a new mechanism by which transplanted stem cells treat ...
May 18, 2021
0
66
Researchers at Baylor College of Medicine have followed the progression of breast cancer in an animal model and discovered a path that transforms a slow-growing type of cancer known as estrogen receptor (ER)+/HER2+ into a ...
May 17, 2021
0
49
Inserm teams led by Laurent Reber (Infinity, Toulouse) and Pierre Bruhns (Humoral Immunity, Institut Pasteur, Paris) and French company NEOVACS have developed a vaccine that could induce long-term protection against allergic ...
May 17, 2021
0
199
